Back
Arcturus Therapeutics Holdings, Inc. Stock Predictions
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
26
ARCT
Arcturus Therapeutics Holdings, Inc.
Last Price:
$8.36
Seasonality Move:
12.44%
7 Day Trial
ALL ACCESS PASS
$
7
Arcturus Therapeutics Holdings, Inc. Stock Forecast
-
Over the next 52 weeks, Arcturus Therapeutics Holdings, Inc. has on average historically risen by 15.6% based on the past 12 years of stock performance.
-
Arcturus Therapeutics Holdings, Inc. has risen higher in 3 of those 12 years over the subsequent 52-week period, corresponding to a historical accuracy of 25%
-
Is Arcturus Therapeutics Holdings, Inc. Stock Undervalued?The current Arcturus Therapeutics Holdings, Inc. [ARCT] share price is $8.23. The Score for ARCT is 26, which is 48% below its historic median score of 50, and infers higher risk than normal.
-
ARCT is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
Will Arcturus Therapeutics Holdings, Inc. Stock Go Up Next Year?
-
Over the next 52 weeks, Arcturus Therapeutics Holdings, Inc. has on average historically risen by 15.6% based on the past 12 years of stock performance.
Arcturus Therapeutics Holdings, Inc. Stock Rating
Sell
26
Arcturus Therapeutics Holdings, Inc. (ARCT)
is a Sell
Is Arcturus Therapeutics Holdings, Inc. overpriced?
-
Arcturus Therapeutics Holdings, Inc. has risen higher in 3 of those 12 years over the subsequent 52-week period, corresponding to a historical accuracy of 25%
Arcturus Therapeutics Holdings, Inc. Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
arcturusrx.com
52-Week Data
52-Week High:
24.17
52-Week Low:
5.85
Prediction Charts
Market Cap:
233.8M
Price in USD:
8.23
Volume:
318.9K
Beta:
2.49
Technical Analysis
SMA50:
7.23
SMA100:
9.47
SMA200:
12.16
52-Wk Change:
-48.75%
Stock Predictions
-
Is Arcturus Therapeutics Holdings, Inc. stock public?Yes, Arcturus Therapeutics Holdings, Inc. is a publicly traded company.
-
What is the Arcturus Therapeutics Holdings, Inc. stock quote today?The Arcturus Therapeutics Holdings, Inc. stock price is 8.23 USD today.
-
How to buy Arcturus Therapeutics Holdings, Inc. stock online?You can buy Arcturus Therapeutics Holdings, Inc. shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Feb-9 | 7.56 | 7.53 | 7.56 | 7.20 |
| Feb-10 | 7.54 | 7.57 | 7.94 | 7.50 |
| Feb-11 | 7.50 | 7.40 | 7.60 | 7.17 |
| Feb-12 | 7.42 | 7.17 | 7.68 | 7.11 |
| Feb-13 | 7.16 | 7.21 | 7.45 | 7.05 |
| Feb-17 | 7.17 | 7.40 | 7.47 | 7.17 |
| Feb-18 | 7.39 | 7.51 | 7.69 | 7.31 |
| Feb-19 | 7.51 | 7.97 | 8.00 | 7.45 |
| Feb-20 | 7.79 | 7.67 | 7.93 | 7.54 |
| Feb-23 | 7.67 | 7.67 | 8.23 | 7.64 |
| Feb-24 | 7.70 | 8.18 | 8.40 | 7.67 |
| Feb-25 | 8.26 | 8.30 | 8.65 | 8.26 |
| Feb-26 | 8.30 | 8.32 | 8.40 | 8.05 |
| Feb-27 | 8.15 | 8.23 | 8.48 | 8.06 |
Arcturus Therapeutics Holdings, Inc. Earnings
Arcturus Therapeutics Holdings, Inc. Earnings Report: Per Share Arcturus Therapeutics Holdings, Inc. Earnings Q1 Q2 Q3 and Q4 last year and next year.
Arcturus Therapeutics Holdings, Inc. Forecast Revenue Growth
Arcturus Therapeutics Holdings, Inc. Stock Analysis: Historical quarterly revenues per share for Arcturus Therapeutics Holdings, Inc. and historical quarterly revenue growth:
-
Analysts estimate an earnings decrease this quarter of $0.56 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.54 per share, and an increase next year of $2.05 per share.
* Arcturus Therapeutics Holdings, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.